FiltersReset Filters

With box warnings

Without box warnings

Branded

Generic

12 results

bendamustine hydrochloride
(bendamustine hydrochloride)
Baxter Healthcare Corporation
Usage: Bendamustine Hydrochloride Injection is indicated for adult patients with chronic lymphocytic leukemia (CLL) and for those with indolent B-cell non-Hodgkin lymphoma (NHL) that has progressed during or within six months of treatment with rituximab or a rituximab-containing regimen.
copiktra
(duvelisib)
Secura Bio, Inc.
Usage: COPIKTRA is indicated for treating adult patients with relapsed or refractory chronic lymphocytic leukemia (CLL) or small lymphocytic leukemia (SLL) who have undergone at least two prior therapies.
cyclophosphamide
(Cyclophosphamide)
NorthStar RxLLC
Usage: Cyclophosphamide for injection is indicated for treating various malignant diseases, including advanced lymphomas, multiple myeloma, leukemias, mycosis fungoides, neuroblastoma, ovarian adenocarcinoma, retinoblastoma, and breast carcinoma. It is also used for pediatric patients with minimal change nephrotic syndrome who do not respond to corticosteroids.
cyclophosphamide
(cyclophosphamide)
Baxter Healthcare Corporation
Usage: Cyclophosphamide for Injection is indicated for treating various malignancies in adults and pediatric patients, including malignant lymphomas, multiple myeloma, leukemias, and specific cancers like breast and ovarian carcinoma. It's also used for pediatric minimal change nephrotic syndrome when corticosteroid therapy fails.
cyclophosphamide
(Cyclophosphamide)
Amneal Pharmaceuticals LLC
Usage: Cyclophosphamide for injection is indicated for treating various malignant diseases, including advanced lymphomas, multiple myeloma, several types of leukemia, mycosis fungoides, neuroblastoma, ovarian adenocarcinoma, retinoblastoma, and breast carcinoma. It is also used for pediatric minimal change nephrotic syndrome unresponsive to corticosteroids.
cyclophosphamide
(cyclophosphamide)
Bamboo US Bidco LCC
Usage: Cyclophosphamide is indicated for treating various malignant diseases, including lymphomas, multiple myeloma, leukemias, mycosis fungoides, neuroblastoma, ovarian adenocarcinoma, retinoblastoma, and breast carcinoma. It is also used for pediatric minimal change nephrotic syndrome unresponsive to corticosteroids. Safety in adults for this condition is not established.
gazyva
(obinutuzumab)
Genentech, Inc.
Usage: GAZYVA is indicated for treating chronic lymphocytic leukemia (CLL) in combination with chlorambucil, and for follicular lymphoma (FL) in combination with bendamustine or chemotherapy, followed by monotherapy. It is used for relapsed/refractory FL post-rituximab and for untreated stage II bulky, III or IV FL.
imbruvica
(Ibrutinib)
Pharmacyclics LLC
Usage: IMBRUVICA is indicated for adult patients with chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), CLL/SLL with 17p deletion, Waldenström’s macroglobulinemia, and for treating chronic graft-versus-host disease in patients aged 1 year and older after failure of prior systemic therapy.
jaypirca
(pirtobrutinib)
Eli Lilly and Company
Usage: JAYPIRCA® is indicated for adult patients with relapsed or refractory mantle cell lymphoma (MCL) after at least two systemic therapies, including a BTK inhibitor. It is also indicated for chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) after two prior therapies, including a BTK and a BCL-2 inhibitor.
rituxan hycela
(rituximab and hyaluronidase)
Genentech, Inc.
Usage: RITUXAN HYCELA is indicated for adult patients with relapsed/refractory and previously untreated follicular lymphoma, as maintenance therapy or after CVP chemotherapy. It treats diffuse large B-cell lymphoma in combination with CHOP, and chronic lymphocytic leukemia with fludarabine and cyclophosphamide. Not for non-malignant conditions.

Medications for Chronic Lymphocytic Leukemia

bendamustine hydrochloride

copiktra

cyclophosphamide

cyclophosphamide

cyclophosphamide

cyclophosphamide

gazyva

imbruvica

jaypirca

rituxan hycela